In silico screening of FDA approved drugs on AXL kinase and validation for breast cancer cell line

References

• Baker, N. A., Sept, D., Joseph, S., Holst, M. J., & McCammon, J. A. (2001). Electrostatics of nanosystems: Application to microtubules and the ribosome. Proceedings of the National Academy of Sciences of the United States of America, 98(18), 10037–10041. doi:10.1073/pnas.181342398
   PubMed Web of Science ®Google Scholar
• Berclaz, G., Altermatt, H. J., Rohrbach, V., Kieffer, I., Dreher, E., & Andres, A. C. (2001). Estrogen dependent expression of the receptor tyrosine kinase AXL in normal and malignant human breast. Annals of Oncology, 12(6), 819–824. doi:10.1023/A:1011126330233
   PubMed Web of Science ®Google Scholar
• Burbridge, M. F., Bossard, C. J., Saunier, C., Fejes, I., Bruno, A., Léonce, S., Ferry, G., Da Violante, G., Bouzom, F., Cattan, V., Jacquet-Bescond, A., Comoglio, P. M., Lockhart, B. P., Boutin, J. A., Cordi, A., Ortuno, J. C., Pierré, A., Hickman, J. A., Cruzalegui, F. H., & Depil, S. (2013). S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab. Molecular Cancer Therapeutics, 12(9), 1749–1762. doi:10.1158/1535-7163.MCT-13-0075
   PubMed Web of Science ®Google Scholar
• Bussi, G., Donadio, D., & Parrinello, M. (2007). Canonical sampling through velocityrescaling. Journal of Chemical Physics, 126(1), 014101. doi:10.1063/1.2408420
   PubMed Web of Science ®Google Scholar
• Chung, B. I., Malkowicz, S. B., Nguyen, T. B., Libertino, J. A., & McGarvey, T. W. (2003). Expression of the proto-oncogene AXL in renal cell carcinoma. DNA and Cell Biology, 22(8), 533–540. doi:10.1089/10445490360708946
   PubMed Web of Science ®Google Scholar
• Craven, R. J., Xu, L., Weiner, T. M., Fridell, Y.-W., Dent, G. A., Srivastava, S., Varnum, B., Liu, E. T., & Cance, W. G. (1995). Receptor tyrosine kinases expressed in metastatic colon cancer. International Journal of Cancer, 60(6), 791–797. doi:10.1002/ijc.2910600611
   PubMed Web of Science ®Google Scholar
• Eder, J. P., Shapiro, G. I., Appleman, L. J., Zhu, A. X., Miles, D., Keer, H., Ancilla, B., Chu, F., Hitchcock-Bryan, S., Sherman, L., McCallum, S., Heath, E. I., Boerner, S. A., & LoRusso, P. M. (2010). A phase I study of foretinib, a multi-targeted inhibitor of c-Met and vascular endothelial growth factor receptor 2. Clinical Cancer Research, 16(13), 3507–3516.
   PubMed Web of Science ®Google Scholar
• Fan, Y., Shi, L. M., Kohn, K. W., Pommier, Y., & Weinstein, J. N. (2001). Quantitative structure-antitumor activity relationships of camptothecin analogues: Cluster analysis and genetic algorithm based studies. Journal of Medicinal Chemistry, 44(20), 3254–3263. doi:10.1021/jm0005151
   PubMed Web of Science ®Google Scholar
• Gaur, A. S., Nagamani, S., Tanneeru, K., Druzhilovskiy, D., Rudik, A., Poroikov, V., & Sastry, G. N. (2018). Molecular property diagnostic suite for diabetes mellitus (MPDS(DM)): An integrated web portal for drug discovery and drug repurposing. Journal of Biomedical Informatics, 85, 114–125. doi:10.1016/j.jbi.2018.08.003
   PubMed Web of Science ®Google Scholar
• Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., Hornik, K., Hothorn, T., Huber, W., Iacus, S., Irizarry, R., Leisch, F., Li, C., Maechler, M., Rossini, A. J., … Zhang, J. (2004). Bioconductor: Open software development for computational biology and bioinformatics. Genome Biology, 5, R80. doi:10.1186/gb-2004-5-10-r80
   PubMed Web of Science ®Google Scholar
• Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. doi:10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Web of Science ®Google Scholar
• Holland, S. J., Pan, A., Franci, C., Hu, Y., Chang, B., Li, W., Duan, M., Torneros, A., Yu, J., Heckrodt, T. J., Zhang, J., Ding, P., Apatira, A., Chua, J., Brandt, R., Pine, P., Goff, D., Singh, R., Payan, D. G., & Hitoshi, Y. (2010). R428, a selective small molecule inhibitor of AXL kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. Cancer Research, 70(4), 1544–1554.
   PubMed Web of Science ®Google Scholar
• Ito, T., Ito, M., Naito, S., Ohtsuru, A., Nagayama, Y., Kanematsu, T., Yamashita, S., & Sekine, I. (1999). Expression of the AXL receptor tyrosine kinase in human thyroid carcinoma. Thyroid, 9(6), 563–567. doi:10.1089/thy.1999.9.563
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumari, R., & Open Source Drug Discovery Consortium (2014). Open source drug discovery consortium, Lynn A. g_MMPBSA–a GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962., Kumar, R., & Lynn, A. doi:10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Lemke, G., & Rothlin, C. V. (2008). Immunobiology of the TAM receptors. Nature Reviews Immunology, 8(5), 327–336.
   PubMed Web of Science ®Google Scholar
• Li, Y., Ye, X., Tan, C., Hongo, J. A., Zha, J., Liu, J., Kallop, D., Ludlam, M. J., & Pei, L. (2009). AXL as a potential therapeutic target in cancer: Role of AXL in tumor growth, metastasis and angiogenesis. Oncogene, 28(39), 3442–3455. doi:10.1038/onc.2009.212
   PubMed Web of Science ®Google Scholar
• Linger, R. M., Keating, A. K., Earp, H. S., & Graham, D. K. (2008). TAM receptor tyrosine kinases: Biologic functions, signaling, and potential therapeutic targeting in human cancer. Advances in Cancer Research, 100, 35–83. doi:10.1016/S0065-230X(08)00002-X
   PubMed Web of Science ®Google Scholar
• Meric, F., Lee, W. P., Sahin, A., Zhang, H., Kung, H. J., & Hung, M. C. (2002). Expression profile of tyrosine kinases in breast cancer. Clinical Cancer Research, 8(2), 361–367.
   PubMed Web of Science ®Google Scholar
• Mori, M., Kaneko, N., Ueno, Y., Tanaka, R., Cho, K., Saito, R., Kondoh, Y., Shimada, I., & Kuromitsu, S. (2014). ASP2215, a novel FLT3/AXL inhibitor: Preclinical evaluation in acute myeloid leukemia (AML). Journal of Clinical Oncology, 32(15_suppl), 7070–7070. doi:doi:10.1200/jco.2014.32.15_suppl.7070
   Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). Autodock4 and AutoDockTools4: Automated docking with selective receptor flexiblity. Journal of Computational Chemistry, 16, 2785–2791. doi:10.1002/jcc.21256
   Web of Science ®Google Scholar
• O’Bryan, J. P., Frye, R. A., Cogswell, P. C., Neubauer, A., Kitch, B., Prokop, C., Espinosa, R., 3rd, Le Beau, M. M., Earp, H. S., & Liu, E. T. (1991). AXL, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Molecular and Cellular Biology, 11, 5016–5031. doi:10.1128/mcb.11.10.5016
   PubMed Web of Science ®Google Scholar
• Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics. , 52(12), 7182–7190. doi:10.1063/1.328693
   Web of Science ®Google Scholar
• R Core Team. (2013). R: a language and environment for statistical computing. R Foundation for Statistical Computing. http://www.R-project.org.
   Google Scholar
• Roy, K., Kar, S., & Das, R. (2015a). QSAR/QSPR modeling: Introduction. In A primer on QSAR/QSPR Modeling (pp. 1–36). Springer International Publishing.
   Google Scholar
• Roy, K., Kar, S., & Das, R. (2015b). Statistical methods in QSAR/QSPR. In A primer on QSAR/QSPR modeling (pp. 37–59). Springer International Publishing.
   Google Scholar
• Sainaghi, P. P., Castello, L., Bergamasco, L., Galletti, M., Bellosta, P., & Avanzi, G. C. (2005). Gas6 induces proliferation in prostate carcinoma cell lines expressing the AXL receptor. Journal of Cellular Physiology, 204(1), 36–44. doi:10.1002/jcp.20265
   PubMed Web of Science ®Google Scholar
• Schmidt, T., Ben-Batalla, I., Schultze, A., & Loges, S. (2012). Macrophage-tumor crosstalk: Role of TAMR tyrosine kinase receptors and of their ligands. Cellular and Molecular Life Sciences, 69(9), 1391–1414. doi:10.1007/s00018-011-0863-7
   PubMed Web of Science ®Google Scholar
• Schroeder, G. M., An, Y., Cai, Z.-W., Chen, X.-T., Clark, C., Cornelius, L. A. M., Dai, J., Gullo-Brown, J., Gupta, A., Henley, B., Hunt, J. T., Jeyaseelan, R., Kamath, A., Kim, K., Lippy, J., Lombardo, L. J., Manne, V., Oppenheimer, S., Sack, J. S., … Borzilleri, R. M. (2009). Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily. Journal of Medicinal Chemistry, 52(5), 1251–1254. doi:10.1021/jm801586s
   PubMed Web of Science ®Google Scholar
• Shamsara, J. (2017). EZQSAR: An R package for developing QSAR models directly from structures. The Open Medicinal Chemistry Journal, 11(1), 212–221.
   PubMedGoogle Scholar
• Shieh, Y. S., Lai, C. Y., Kao, Y. R., Shiah, S. G., Chu, Y. W., Lee, H. S., & Wu, C. W. (2005). Expression of AXL in lung adenocarcinoma and correlation with tumor progression. Neoplasia (New York, N.Y.), 7(12), 1058–1064. doi:10.1593/neo.05640
   PubMed Web of Science ®Google Scholar
• Steinbeck, C., Hoppe, C., Kuhn, S., Floris, M., Guha, R., & Willighagen, E. L. (2006). Recent developments of the chemistry development kit (CDK)—An open-source java library for chemo- and bioinformatics. Current Pharmaceutical Design, 12(17), 2111–2120. doi:10.2174/138161206777585274
   PubMed Web of Science ®Google Scholar
• Sun, W., Fujimoto, J., & Tamaya, T. (2004). Coexpression of Gas6/AXL in human ovarian cancers. Oncology, 66(6), 450–457. doi:10.1159/000079499
   PubMed Web of Science ®Google Scholar
• Szabadkai, I., Torka, R., Garamvölgyi, R., Baska, F., Gyulavári, P., Boros, S., Illyés, E., Choidas, A., Ullrich, A., & Őrfi, L. (2018). Discovery of N-[4-(Quinolin-4 yloxy)phenyl]benzenesulfonamides as Novel AXL Kinase Inhibitors. Journal of Medicinal Chemistry, 61(14), 6277–6292. doi:10.1021/acs.jmedchem.8b00672
   PubMed Web of Science ®Google Scholar
• Todeschini, R., Ballabio, D., & Grisoni, F. (2016). Beware of unreliable Q(2)! A comparative study of regression metrics for predictivity assessment of QSAR models. Journal of Chemical Information and Modeling, 56(10), 1905–1913. doi:10.1021/acs.jcim.6b00277
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. Journal of Computational Chemistry, 31, 455–461. doi:10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• Veerasamy, R., Rajak, H., Jain, A., Sivadasan, S., Varghese, C. P., & Agrawal, R. K. (2011). Validation of QSAR models—Strategies and importance. International Journal of Drug Design and Discovery, 2, 511–519.
   Google Scholar
• Venkanna, A., Siva, B., Poornima, B., Rao Vadaparthi, P. R., Rajendra Prasad, K., Ashok Reddy, K., Bhanu Prakash Reddy, G., & Suresh Babu, K. (2014). Phytochemical investigation of sesquiterpenes from the fruits of Schisandrachinensis and their cytotoxic activity. Fitoterapia, 95, 102–108. doi:10.1016/j.fitote.2014.03.003
   PubMed Web of Science ®Google Scholar
• Wang, Y., Xing, L., Ji, Y., Ye, J., Dai, Y., Gu, W., Ai, J., & Song, Z. (2019). Discovery of a potent tyrosine kinase AXL inhibitor bearing the 3-((2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)amino)pyrazine core. Bioorganic and Medicinal Chemistry Letters, 29(6), 836–838. doi:10.1016/j.bmcl.2019.01.018
   PubMed Web of Science ®Google Scholar
• Wu, C. W., Li, A. F., Chi, C. W., Lai, C. H., Huang, C. L., Lo, S. S., Lui, W. Y., & Lin, W. C. (2002). Clinical significance of AXL kinase family in gastric cancer. Anticancer Research, 22(2B), 1071–1078.
   PubMed Web of Science ®Google Scholar